Tag: Europace 2017
Repeat ablation with contact force sensing “does not necessarily guarantee a...
Preliminary results from the ABLATOR observational registry have shown similar success rates (around 58%) in first time ablation and repeat ablation for persistent atrial...
Cardiac resynchronisation therapy guided by imaging: The next step for optimal...
Jonathan Behar (London, UK) co-inventor for the Guide CRT platform—shortlisted as a 2017 finalist for the EHRA Inventors Award—details the benefits of this novel...
EHRA Inventors Award ideas focus on cardiac remote monitoring and CRT...
For the second-year running, the European Heart Rhythm Association (EHRA) held the EHRA Inventors Award competition at EHRA-EUROPACE CARDIOSTIM (18‒21 June, Vienna, Austria), a...
Europace 2017: Thrombus formation on left atrial appendage occlusion devices strongly...
A French multicentre analysis of left atrial appendage (LAA) occlusion for stroke prevention in atrial fibrillation patients has found a 5.3% rate of thrombus...
Europace 2017: Breast implants may lead to false heart attack diagnosis
Breast implants may disrupt an electrocardiogram (ECG) and could result in a false heart attack diagnosis, according to research presented at EHRA EUROPACE -...
Europace 2017: Stroke history higher in asymptomatic versus symptomatic atrial fibrillation...
Newly diagnosed asymptomatic atrial fibrillation patients have a higher rate of previous stroke than those with symptoms, according to results from the GLORIA-AF registry...